Pacira BioSciences (PCRX) – Analyst Ratings
-
JPMorgan Assumes Pacira Pharmaceuticals (PCRX) at Overweight, 'Shares Well Positioned Ahead of Catalysts'
-
Raymond James Starts Pacira Pharmaceuticals (PCRX) at Outperform
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
Back to PCRX Stock Lookup